As of June 10, 2025, CV Sciences Inc (CVSI) reports a Net Margin of -15.24%.
Net Margin shows the share of revenue that becomes profit after all costs, reflecting overall profitability.
Historical Trend of CV Sciences Inc's Net Margin
Over recent years, CV Sciences Inc's Net Margin has shown a stable trend. The table below summarizes the historical values:
| Date | Net Margin |
|---|---|
| 2024-12-31 | -15.24% |
| 2023-12-31 | 19.38% |
| 2022-12-31 | -50.69% |
| 2021-12-31 | -77.58% |
| 2020-12-31 | -91.22% |
This slight upward trend highlights how CV Sciences Inc manages its overall profitability and cost control over time.
Comparing CV Sciences Inc's Net Margin to Peers
To better understand CV Sciences Inc's position, it's useful to compare its Net Margin against industry peers. Below are selected comparisons:
| Company | Net Margin |
|---|---|
| CV Sciences Inc (CVSI) | -15.24% |
| Baikang Biological Group Holdings Ltd (BKSW) | 55.68% |
| United-Guardian Inc (UG) | 26.69% |
| Creative Edge Nutrition Inc (FITX) | 21.31% |
| FitLife Brands Inc (FTLF) | 13.94% |
| Scott's Liquid Gold-Inc (SLGD) | 11.17% |
Compared to its competitors, CV Sciences Inc's Net Margin is about average compared to peers, reflecting typical industry profitability.